Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

2(50.0%)

Phase 3

1(25.0%)

Phase 1

1(25.0%)

4Total

Phase 2(2)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00080119Phase 2Terminated

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Role: collaborator

NCT00068991Phase 1Withdrawn

HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

Role: collaborator

NCT00346762Completed

Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

Role: collaborator

NCT00234091Phase 3Completed

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Role: collaborator

NCT00279331Completed

Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador

Role: collaborator

NCT00371592Phase 2Completed

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Role: collaborator

NCT00346476Completed

Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa

Role: collaborator

All 7 trials loaded